γ-synuclein is a promising new marker for staining reactive follicular dendritic cells, follicular dendritic cell sarcoma, Kaposi sarcoma, and benign and malignant vascular tumors

American Journal of Surgical Pathology

Volumn 35, Issue 12, 2011, Pages 1857-1865

  Zhang, Hailing ^a   Maitta, Robert W ^b   Bhattacharyya, Pritish K ^c   Florea, Alina Dulau ^d   Sen, Filiz ^e   Wang, Qing ^f   Ratech, Howard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^e North Shore Long Island Jewish Health System ^*  (United States)

^f TEMPLE UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

synuclein; angiosarcoma; follicular dendritic cell; follicular dendritic cell sarcoma; Kaposi sarcoma

Indexed keywords

GAMMA SYNUCLEIN; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; FOLLICULAR DENDRITIC CELL; FOLLICULAR DENDRITIC CELL SARCOMA; HUMAN; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; LYMPHOMA; METABOLISM; PATHOLOGY; PSEUDOLYMPHOMA; RETROSPECTIVE STUDY; TISSUE MICROARRAY;

DENDRITIC CELL SARCOMA, FOLLICULAR; DENDRITIC CELLS, FOLLICULAR; GAMMA-SYNUCLEIN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; PSEUDOLYMPHOMA; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 81355146730     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182297c2e     Document Type: Article

References (37)

1. Ahmad M, Attoub S, Singh MN, et al. Gamma-synuclein and the progression of cancer. FASEB J. 2007;21:3419-3430.
2. Allen CD, Cyster JG. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin Immunol. 2008;20:14-25.
3. Arber DA, Strickler JG, Chen YY, et al. Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol. 1997;21:827-835. (Pubitemid 27406553)
4. Barbour R, Kling K, Anderson JP, et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 2008; 5:55-59.
5. Benezech C, White A, Mader E, et al. Ontogeny of stromal organizer cells during lymph node development. J Immunol. 2010; 184:4521-4530.
6. Bruening W, Giasson BI, Klein-Szanto AJ, et al. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer. 2000;88:2154-2163. (Pubitemid 30233219)
7. Buchman VL, Adu J, Pinon LG, et al. Persyn, a member of the synuclein family, influences neurofilament network integrity. Nat Neurosci. 1998;1:101-103.
8. Burre J, Sharma M, Tsetsenis T, et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010; 329:1663-1667.
9. Clayton DF, George JM. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 1998;21:249-254. (Pubitemid 28239982)
10. de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007;109:4952-4963. (Pubitemid 46827794)
11. Galvin JE, Uryu K, Lee VM, et al. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci USA. 1999; 96:13450-13455.
12. Grogg KL, Lae ME, Kurtin PJ, et al. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol. 2004;28:988-998. (Pubitemid 38971422)
13. Grogg KL, Macon WR, Kurtin PJ, et al. A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. Mod Pathol. 2005;18:260-266. (Pubitemid 40188634)
14. Jakes R, Spillantini MG, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett. 1994;345:27-32. (Pubitemid 24154659)
15. Ji H, Liu YE, Jia T, et al. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res. 1997;57:759-764. (Pubitemid 27085663)
16. Lavedan C, Leroy E, Dehejia A, et al. Identification, localization and characterization of the human gamma-synuclein gene. Hum Genet. 1998;103:106-112. (Pubitemid 28398395)
17. Liu C, Dong B, Lu A, et al. Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen. BMC Cancer. 2010;10:359.
18. Maitta RW,Wolgast LR, Wang Q, et al. Alpha-and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia. Am J Hematol. 2011;86:230-234.
19. Martin TA, Gomez K, Watkins G, et al. Expression of breast cancer specific gene-1 (BCSG-1/gamma-synuclein) is associated with tumour grade but not with clinical outcome of patients with breast cancer. Oncol Rep. 2006;16:207-212.
20. Mesquita RA, de Araujo VC, Paes RA, et al. Immunohistochemical analysis for CD21, CD35, Caldesmon and S100 protein on dendritic cells types in oral lymphomas. J Appl Oral Sci. 2009;17:248-253.
21. Mohrmann R, de Wit H, Verhage M, et al. Fast vesicle fusion in living cells requires at least three SNARE complexes. Science. 2010;330:502-505.
22. Munoz-Fernandez R, Blanco FJ, Frecha C, et al. Follicular dendritic cells are related to bone marrow stromal cell progenitors and to myofibroblasts. J Immunol. 2006;177:280-289. (Pubitemid 43939139)
23. Nakai M, Fujita M, Waragai M, et al. Expression of alphasynuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage. Biochem Biophys Res Commun. 2007;358: 104-110. (Pubitemid 46719086)
24. Nakamura S, Nagahama M, Kagami Y, et al. Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: a clinicopathologic study of nine cases. Am J Surg Pathol. 1999;23:363-376. (Pubitemid 29159997)
25. Papadaki T, Stamatopoulos K, Belessi C, et al. Splenic marginalzone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases. Am J Surg Pathol. 2007;31:438-446. (Pubitemid 46673118)
26. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045-2047. (Pubitemid 27443610)
27. Rademakers LH. Dark and light zones of germinal centres of the human tonsil: an ultrastructural study with emphasis on heterogeneity of follicular dendritic cells. Cell Tissue Res. 1992;269: 359-368.
28. Sabin F. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic in the pig. Am J Anat. 1902;1:367-389.
29. Segrest JP, Jones MK, De Loof H, et al. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res. 1992;33:141-166.
30. Soriano AO, Thompson MA, Admirand JH, et al. Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature. Am J Hematol. 2007;82:725-728. (Pubitemid 47221654)
31. Spillantini MG, Divane A, Goedert M. Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35. Genomics. 1995;27:379-381.
32. Surgucheva I, McMahon B, Surguchov A. Gamma-synuclein has a dynamic intracellular localization. Cell Motil Cytoskeleton. 2006;63: 447-458. (Pubitemid 44162634)
33. Tu Y, Salim S, Bourgeois J, et al. CD23-mediated IgE transport across human intestinal epithelium: inhibition by blocking sites of translation or binding. Gastroenterology. 2005;129:928-940. (Pubitemid 41242685)
34. Vermi W, Lonardi S, Bosisio D, et al. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma. J Pathol. 2008; 216:356-364.
35. Vondenhoff MF, van de Pavert SA, Dillard ME, et al. Lymph sacs are not required for the initiation of lymph node formation. Development. 2009;136:29-34.
36. Xie Q, Chen L, Fu K, et al. Podoplanin (D2-40): a new immunohistochemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas. Int J Clin Exp Pathol. 2008; 1:276-284.
37. Yu H, Gibson JA, Pinkus GS, et al. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors. Am J Clin Pathol. 2007; 128:776-782. (Pubitemid 350133988)